Page last updated: 2024-10-15

dinitrochlorobenzene and Parkinson Disease

dinitrochlorobenzene has been researched along with Parkinson Disease in 1 studies

Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Im, JY1
Lee, KW1
Woo, JM1
Junn, E1
Mouradian, MM1

Other Studies

1 other study available for dinitrochlorobenzene and Parkinson Disease

ArticleYear
DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.
    Human molecular genetics, 2012, Jul-01, Volume: 21, Issue:13

    Topics: Animals; Antioxidants; Cell Line, Tumor; Cytoprotection; Dinitrochlorobenzene; Gene Expression Regul

2012